Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Trial Group- Pre-diagnosed subjects of Madhumeha; Type 2 DM (on oral hypoglycemics but not on Insulin therapy) of either gender, in age group 40-60 years with minimum 10 years of diabetic history. Control Group- Non-diabetic healthy subjects in the age group 40-60 years with no history or features of Madhumeha, any autoimmune and metabolic disorders.
Exclusion criteria
Exclusion criteria: Subjects suffering with Autoimmune disorders. Subjects suffering with Tuberculosis, Cancer, Jaundice. Subjects suffering with Rajyakshma, Shosha, Grahani, Pandu. Subjects on medication for any infective disease. Subjects not willing to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint â?? Status of Ojas as determined through total score of Ojas Assessment Scale in the patients of Madhumeha; Type 2 Diabetes mellitus in comparison to healthy non-diabetic controls.Timepoint: December 2022 | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpoint â?? Levels of Serum Total IgG, RBC Transmembrane proteins (GLUT-1, Band-3) and RBC Cytoskeletal proteins (Alpha-Spectrin, Beta-Spectrin) in the patients of Madhumeha; Type 2 Diabetes mellitus in comparison to healthy non-diabetic controls. Timepoint: December 2022 | — |
Countries
India
Contacts
All India Institute of Ayurveda, New Delhi